Abstract
Primary cutaneous T cell lymphomas (CTCL) represent a heterogeneous group of T lymphomas. Virus involvement in CTCL pathogenesis has been extensively investigated, but no data are available as to a causative role of parvovirus B19. The prevalence of parvovirus variants (B19, LaL1/K71, V9) was investigated by using two nested PCRs and a genotype-2 semiquantitative PCR (Q-PCR). Parvovirus DNA was detected in similar percentage in healthy skin controls (40%; n = 42), inflammatory dermatoses (ID) (41%; n = 80) and CTCL (34%; n = 76). Among variants, genotype-2 was more prevalent in ID (26%) and CTCL (22%) than in normal skin (14%; p < 0.05). genotype-3 was never found in normal skin and was rare in ID. The only four pathological skin samples with a quantifiable genome copies/μg DNA values in Q-PCR were ID. In conclusion, despite the skin represent a reservoir for genotype-1, parvovirus infection is not involved in the etiopathogenesis of CTCL.
Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Baskan EB, Yilmaz E, Saricaoglu H et al (2007) Detection of parvovirus B19 DNA in the lesional skin of patients with Behçet’s disease. Clin Exp Dermatol 32:186–190. doi:10.1111/j.1365-2230.2006.02330.x
Bergallo M, Costa C, Sidoti F et al (2008) Variants of parvovirus B19: bioinformatical evaluation of nested PCR assays and genotypes detection. Intervirol 51:75–80. doi:10.1159/000127429
Bernengo MG, Novelli M, Quaglino P et al (2001) The relevance of the CD4 + CD26—subset in the identification of circulating Sezary cells. Br J Dermatol 144:124–135. doi:10.1046/j.1365-2133.2001.04014.x
Brown KE, Young NS (1997) Parvovirus B19 in human disease. Annu Rev Med 48:59–67. doi:10.1146/annurev.med.48.1.59
Chevrel G, Calyet A, Belin V et al (2000) Dermatomyositis associated with the presence of parvovirus B19 DNA in muscle. Rheumatology (Oxford) 39:1037–1039. doi:10.1093/rheumatology/39.9.1037
Crowson AN, Magro CN, Dawood MR (2000) A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes. J Cutan Pathol 27:505–515. doi:10.1034/j.1600-0560.2000.027010505.x
Drago F, Semino M, Rampini P et al (1999) Parvovirus B19 infection associated with acute hepatitis and a purpuric exanthem. Br J Dermatol 141:160–161. doi:10.1046/j.1365-2133.1999.02943.x
Ekman A, Hokynar K, Kakkola L et al (2007) Biological and immunological relations among Human Parvovirus B19 genotypes 1 to 3. J Virol 81:6927–6935. doi:10.1128/JVI.02713-06
Ferri C, Azzi A, Magro CM (2005) Parvovirus B19 and systemic sclerosis. Br J Dermatol 152:819–820. doi:10.1111/j.1365-2133.2005.06515.x
Florea AV, Ionescu DN, Melhem MF (2007) Parvovirus B19 infection in the immunocompromised host. Arch Pathol Lab Med 131:799–804
Heegaard ED, Panum Jensen I, Christensen J (2001) Novel PCR assay for differential detection and screening of erythrovirus B19 and erythrovirus V9. J Med Virol 65:362–367. doi:10.1002/jmv.2042
Heegaard ED, Brown KE (2002) Human parvovirus B19. Clin Microbiol Rev 15:485–505. doi:10.1128/CMR.15.3.485-505.2002
Hokynar K, Soderlund-Venermo M, Pesonen M et al (2002) A new parvovirus genotype-persistent in human skin. Virology 302:224–228. doi:10.1006/viro.2002.1673
Katta R (2002) Parvovirus B19: a review. Dermatol Clin 20:333–342. doi:10.1016/S0733-8635(01)00013-4
Kerr S, O’keeffe G, Kilty C et al (1999) Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG. J Med Virol 57:179–185. doi:10.1002/(SICI)1096-9071(199902)57:2<179::AID-JMV16>3.0.CO;2-T
Labarthe MP, Salomon D, Saurat JH (1996) Ulcération linguales, parapsoriasis en gouttes et primo-infection a parvovirus B19. Ann Dermatol Venereol 123:735–738
Magro CM, Dawood MR, Crowson AN (2000) The cutaneous manifestations of human parvovirus B19 infection. Hum Pathol 31:488–497. doi:10.1053/hp.2000.6714
Nagore E, Ledesda E, Collado C et al (2000) Detection of Epstein–Barr virus and human herpesvirus 7 and 8 genomes in primary cutaneous T and B-cell lymphomas. Br J Dermatol 14:320–323. doi:10.1046/j.1365-2133.2000.03657.x
Nguyen QT, Sifer C, Schneider V et al (1999) Novel human erythrovirus associated with transient aplastic anemia. J Clin Microbiol 37:2483–2487
Nguyen QT, Wong S, Heegaard ED et al (2002) Identification and characterization of a second novel human erythrovirus variant, A6. Virology 301:374–380. doi:10.1006/viro.2002.1585
Norja P, Hokynar K, Aaltonen LM et al (2006) Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci USA 103:7450–7474. doi:10.1073/pnas.0602259103
Novelli M, Merlino C, Ponti R et al. (2009) Epstein-Barr Virus in cutaneous T-Cell Lymphomas: evaluation of the viral presence and significance in skin and peripheral blood. J Invest Dermatol. doi:10.1038/jid.2008.396
Ofuji S, Yamamoto O (2007) Acute generalized exanthematous pustulosis associated with a human parvovirus B19 infection. J Dermatol 34:121–123. doi:10.1111/j.1346-8138.2006.00230.x
Olsen E, Vonderheid E, Pimpinelli N et al (2007) Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110:1713–1722. doi:10.1182/blood-2007-03-055749
Ohtsuka T, Yamazaki S (2005) Altered prevalence of human parvovirus B19 component genes in systemic sclerosis skin tissue. Br J Dermatol 152:1078–1080. doi:10.1111/j.1365-2133.2005.06567.x
Parsyan A, Kerr S, Owusu-Ofori S (2006) Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic. J Clin Microbiol 44:1367–1375. doi:10.1128/JCM.44.4.1367-1375.2006
Ponti R, Quaglino P, Novelli M et al (2005) T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings. Br J Dermatol 153:565–573. doi:10.1111/j.1365-2133.2005.06649.x
Ponti R, Fierro MT, Quaglino P et al (2008) TCRgamma-chain gene rearrangement by PCR-based GeneScan: diagnostic accuracy improvement and clonal heterogeneity analysis in multiple cutaneous T-cell lymphoma samples. J Invest Dermatol 128:1030–1038. doi:10.1038/sj.jid.5701109
Ponti R, Bergallo M, Costa C et al (2008) Human Herpesvirus 7 detection by real time quantitative PCR in primary cutaneous T cell lymphomas and healthy subjects: lack of a pathogenic role. Br J Dermatol 159:1131–1137. doi:10.1111/j.1365-2133.2008.08575.x
Reid DM, Reid TMS, Brown T et al (1985) Human parvovirus associated arthritis: a clinical and laboratory description. Lancet 1:422–425. doi:10.1016/S0140-6736(85)91146-8
Schwarz TF, Wiersbitzky S, Pambor M (1994) Case report: detection of parvovirus B19 in a skin biopsy of a patient with erythema infectiosum. J Med Virol 43(2):171–174. doi:10.1002/jmv.1890430214
Servant A, Laperche S, Lallemand F et al (2002) Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 76:9124–9134. doi:10.1128/JVI.76.18.9124-9134.2002
Smith PT, Landry ML, Carey H et al (1998) Papular-purpuric gloves and socks syndrome associated with acute parvovirus B19 infection: case report and review. Clin Infect Dis 27:164–168. doi:10.1086/514629
Soderlund-Venermo M, Hokynar K, Nieminen J et al (2002) Persistence of human parvovirus B19 in human tissues. Pathol Biol 50:307–316. doi:10.1016/S0369-8114(02)00307-3
Tomasini D, Tomasini CF, Cerri A et al (2004) Pityriasis lichenoides: a cytotoxic T-cell-mediated skin disorder. Evidence of human parvovirus B19 DNA in nine cases. J Cutan Pathol 31:531–538. doi:10.1111/j.0303-6987.2004.00186.x
Vonderheid EC, Bernengo MG (2003) The Sézary syndrome: hematologic criteria. Hematol Oncol Clin North Am 17:1367–1389. doi:10.1016/S0889-8588(03)00120-5
Vuorinen T, Lammintausta K, Kotilainen P et al (2002) Presence of parvovirus B19 DNA in chronic urticaric and healthy human skin. J Clin Virol 25:217–221. doi:10.1016/S1386-6532(02)00012-4
Willemze R, Jaffe ES, Burg G et al (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 105:3768–3785. doi:10.1182/blood-2004-09-3502
Yazici AC, Aslan G, Baz K et al (2006) A high prevalence of parvovirus B19 DNA in patients with psoriasis. Arch Dermatol Res 298:231–235. doi:10.1007/s00403-006-0678-9
This study was supported in part by a grant from the Regione Piemonte-Ricerca Sanitaria Finalizzata, 2005 A288.
Conflict of interest statement
The authors state no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
F. Sidoti and M. T. Fierro contributed equally to this work.
Rights and permissions
About this article
Cite this article
Sidoti, F., Fierro, M.T., Costa, C. et al. Prevalence and significance of human parvovirus variants in skin from primary cutaneous T cell lymphomas, inflammatory dermatoses and healthy subjects. Arch Dermatol Res 301, 647–652 (2009). https://doi.org/10.1007/s00403-009-0954-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-009-0954-6